90%Confidence
0Views
FDASource
2026-04-16Date
Summary
Second Appco Pharma recall for Prazosin 2mg capsules confirms pattern of nitrosamine contamination across their product line. This increases regulatory scrutiny risk for both Appco and Biocon Pharma's entire manufacturing relationship.
Actionable: Evaluate Biocon Pharma's dependency on Appco for multiple products and potential financial impact of manufacturing disruptions.
AI Confidence: 90%
Data Points
firmAppco Pharma LLC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productPrazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now